<DOC>
	<DOCNO>NCT01558960</DOCNO>
	<brief_summary>Retinoblastoma treatment become focus last year . New treatment develop Dr. Kaneko Japan 1995 test clinical trial . Intra-arterial chemotherapy Melphalan show success patient limited response mark vitreal seeding . For case Intravitreal injection Melphalan successful Japan . In study chemotherapy ( melphalan ) administer intravitreally ( directly eye wall ) response ( short long term ) monitor .</brief_summary>
	<brief_title>Intravitreal Injections Melphalan Retinoblastoma</brief_title>
	<detailed_description>Intravitreal injection Melphalan give case unresponsive chemotherapy vitreal seed disease .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>Retinoblastoma respond chemotherapy Retinoblastoma vitreal seed previous failure IVit Melphalan</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Retinoblastoma</keyword>
</DOC>